Immunologic response to inhaled endotoxin: changes in peripheral cell surface markers in normal individuals

Area of Science:

• Immunology
• Respiratory Medicine

Background:

• Monocyte CD14 expression is known to increase after exposure to lipopolysaccharide (LPS) and organic dusts.
• CD14 is a key receptor on monocytes involved in innate immune responses.

Purpose of the Study:

• To investigate the effect of inhaled lipopolysaccharide (LPS) on monocyte CD14 expression in healthy volunteers.
• To determine if CD14 upregulation correlates with clinical responses to LPS exposure.

Main Methods:

• Nine healthy volunteers inhaled increasing concentrations of LPS (0.5, 5.0, and 20 microg).
• Monocyte CD14 expression was measured using flow cytometry before and up to 6 hours after LPS exposure.
• Clinical responses were assessed, and CD14 levels were compared between those with and without significant clinical events.

Main Results:

• Inhaled LPS did not cause a statistically significant difference in CD14 upregulation compared to placebo.
• While not statistically significant, a higher mean percentage of CD14 upregulation was observed in individuals with a clinically significant event (58.4%) versus those without (13.8%).
• Two participants with a marked clinical response showed substantial CD14 upregulation after LPS exposure.

Conclusions:

• Inhaled LPS does not significantly alter monocyte CD14 expression in healthy individuals.
• A potential, though not statistically significant, association exists between CD14 upregulation and clinical response to LPS.
• Further research with larger sample sizes may be needed to clarify the relationship between LPS exposure, CD14, and clinical outcomes.